Total Revenue is expected to increase by a high single-digit percentage; The Core Tax rate is expected to be between 18-22%. Guidance for FY25 ...
Reports Q4 reported EPS 97c vs. 62c last year. Reports Q4 revenue $14.89B, consensus $14.28B. Pascal Soriot, CEO, AstraZeneca (AZN), ...